These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33517680)

  • 41. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.
    Joham AE; Boyle JA; Zoungas S; Teede HJ
    Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
    Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women.
    Teede HJ; Joham AE; Paul E; Moran LJ; Loxton D; Jolley D; Lombard C
    Obesity (Silver Spring); 2013 Aug; 21(8):1526-32. PubMed ID: 23818329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study.
    Kent J; Dodson WC; Kunselman A; Pauli J; Stone A; Diamond MP; Coutifaris C; Schlaff WD; Alvero R; Casson P; Christman GM; Rosen RM; Hansen KR; Robinson RD; Baker V; Usadi R; Santoro N; Zhang H; Eisenberg E; Legro RS;
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4315-4323. PubMed ID: 30085187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.
    Fornes R; Simin J; Nguyen MH; Cruz G; Crisosto N; van der Schaaf M; Engstrand L; Brusselaers N
    Reprod Biol Endocrinol; 2022 Feb; 20(1):30. PubMed ID: 35130922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 47. Association between hypertensive disorders of pregnancy and the risk of postpartum hypertension: a cohort study in women with gestational diabetes.
    Wang L; Leng J; Liu H; Zhang S; Wang J; Li W; Li W; Li N; Zhang T; Baccarelli AA; Hou L; Yang X; Yu Z; Hu G
    J Hum Hypertens; 2017 Nov; 31(11):725-730. PubMed ID: 28660887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult Pre-pregnancy Weight Change and Risk of Developing Hypertensive Disorders in Pregnancy.
    Adane AA; Mishra GD; Tooth LR
    Paediatr Perinat Epidemiol; 2017 May; 31(3):167-175. PubMed ID: 28386955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
    Haase CL; Varbo A; Laursen PN; Schnecke V; Balen AH
    Hum Reprod; 2023 Mar; 38(3):471-481. PubMed ID: 36637246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New perspectives on the definition and management of polycystic ovary syndrome.
    Pasquali R; Gambineri A
    J Endocrinol Invest; 2018 Oct; 41(10):1123-1135. PubMed ID: 29363047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A population-based follow-up study shows high psychosis risk in women with PCOS.
    Karjula S; Arffman RK; Morin-Papunen L; Franks S; Järvelin MR; Tapanainen JS; Miettunen J; Piltonen TT
    Arch Womens Ment Health; 2022 Apr; 25(2):301-311. PubMed ID: 34841466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
    Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
    Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: A population-based cohort study.
    Kujanpää L; Arffman RK; Pesonen P; Korhonen E; Karjula S; Järvelin MR; Franks S; Tapanainen JS; Morin-Papunen L; Piltonen TT
    Acta Obstet Gynecol Scand; 2022 Jul; 101(7):728-736. PubMed ID: 35673942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.
    González F; Sia CL; Stanczyk FZ; Blair HE; Krupa ME
    Endocrine; 2012 Dec; 42(3):726-35. PubMed ID: 22752961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.